Int J Gynecol Pathol. 2020 Jan;39(1):84-92. doi: 10.1097/PGP.0000000000000573.
Mesonephric-like adenocarcinomas are rare neoplasms occurring in the uterine corpus and ovary which bear a close morphologic resemblance to cervical mesonephric adenocarcinomas. They also have a similar immunophenotype and harbor similar molecular abnormalities to mesonephric adenocarcinomas and it is debated whether they are truly of mesonephric origin or represent Mullerian neoplasms closely mimicking mesonephric adenocarcinomas. We report an unusual case with bilateral ovarian serous borderline tumors and extraovarian low-grade serous carcinoma (invasive implants). In one ovary, there was a component of mesonephric-like adenocarcinoma. The immunophenotypes of the serous and the mesonephric-like components were distinct and as expected for the individual tumor types (serous component diffusely positive with WT1 and estrogen receptor and negative with GATA3, TTF1 and CD10; mesonephric-like component WT1 and estrogen receptor negative and GATA3, TTF1, and CD10 positive; both components diffusely positive with PAX8 and exhibiting "wild-type" p53 immunoreactivity). In all components (bilateral serous borderline tumors, low-grade serous carcinoma and mesonephric-like adenocarcinoma), an identical KRAS mutation was detected (NM_004985.4): c.35G>A, p.(G12D) proving a clonal association between the serous and mesonephric-like components and excluding a collision neoplasm. This represents the second reported case of a combined ovarian low-grade serous tumor and mesonephric-like adenocarcinoma; in the previously reported case, an identical NRAS mutation was present in both components. These 2 cases provide evidence that ovarian mesonephric-like adenocarcinomas have, at least in some cases, a Mullerian origin and differentiate along mesonephric lines. We present additional evidence for this by reviewing associated findings in published and unpublished ovarian mesonephric-like adenocarcinomas; 8 of 11 of these neoplasms contained other Mullerian lesions in the same ovary, mainly endometriosis and adenomas/adenofibromas.
中肾样腺癌是一种罕见的肿瘤,发生于子宫体和卵巢,其形态学上与宫颈中肾样腺癌密切相似。它们也具有相似的免疫表型,并具有与中肾样腺癌相似的分子异常,因此是否真正来源于中肾仍存在争议,或代表类似于中肾样腺癌的 Müller 管肿瘤。我们报告了一个不常见的病例,该病例双侧卵巢有浆液性交界性肿瘤和卵巢外低级别浆液性癌(浸润性种植灶)。在一侧卵巢中,存在中肾样腺癌成分。浆液性和中肾样成分的免疫表型明显不同,与单个肿瘤类型一致(浆液性成分弥漫性 WT1 和雌激素受体阳性,GATA3、TTF1 和 CD10 阴性;中肾样成分 WT1 和雌激素受体阴性,GATA3、TTF1 和 CD10 阳性;两个成分均弥漫性 PAX8 阳性,并表现出“野生型”p53 免疫反应性)。在所有成分(双侧浆液性交界性肿瘤、低级别浆液性癌和中肾样腺癌)中,均检测到相同的 KRAS 突变(NM_004985.4):c.35G>A,p.(G12D),证明了浆液性和中肾样成分之间的克隆关联,并排除了碰撞性肿瘤。这是第二个报道的卵巢低级别浆液性肿瘤和中肾样腺癌合并病例;在之前报道的病例中,两个成分均存在相同的 NRAS 突变。这两个病例为卵巢中肾样腺癌至少在某些情况下具有 Müller 管起源并沿着中肾样分化提供了证据。我们通过回顾已发表和未发表的卵巢中肾样腺癌的相关发现,为这一观点提供了更多证据;在这 11 例中肾样腺癌中,有 8 例在同一卵巢中存在其他 Müller 管病变,主要是子宫内膜异位症和腺瘤/腺纤维瘤。